- American City Business Journals•9 hours ago
The University of Minnesota is suing Gilead Sciences Inc., alleging the pharmaceuticals company's lucrative Hepatitis C drugs infringe on a university patent. In a lawsuit filed in Minnesota's U.S. District Court Monday, the university claimed its intellectual property covers Gilead products that contain the drug sofosbuvir, including those sold under the brand names Sovaldi and Harvoni. The state university system said it brought its patent concerns to Gilead (GILD) in August 2015, but the company continued its alleged infringement.
- Market Realist•10 hours ago
United Therapeutics has projected that in 2016, its trepostinil pulmonary arterial hypertension drugs will benefit from patients' shifting away from Uptravi.
Gilead Sciences Inc. (GILD)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||77.84 x 200|
|Ask||77.99 x 300|
|Day's Range||77.66 - 78.39|
|52wk Range||77.63 - 113.31|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||6.84|
|Avg Vol (3m)||10,225,044|
|Dividend & Yield||1.88 (2.36%)|